GO
Loading...

Johnson & Johnson

More

  • LONDON, Feb 1- As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit another epidemic hard and fast. Determined not to lose scientific momentum that could make the world's first effective Ebola interventions a reality, researchers...

  • Final Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 6:02 PM ET

    Baxter International Inc. fell $1.07 or 1.5 percent, to $70.31. Bristol-Myers Squibb Co. fell$. 87 or 1.4 percent, to $60.27. Hospira fell $1.35 or 2.1 percent, to $63.43.

  • Final Glance: Medical Devices companies Friday, 30 Jan 2015 | 6:02 PM ET

    Allergan fell $3.13 or 1.4 percent, to $219.26. Baxter International Inc. fell $1.07 or 1.5 percent, to $70.31. Boston Scientific Corp. fell$. 04 or. 3 percent, to $14.81.

  • Midday Glance: Medical Devices companies Friday, 30 Jan 2015 | 1:27 PM ET

    Allergan fell $1.70 or. 8 percent, to $220.69. Baxter International Inc. rose$. 07 or. 1 percent, to $71.45. Boston Scientific Corp. fell$. 04 or. 3 percent, to $14.81.

  • Midday Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 1:27 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $71.45. Bristol-Myers Squibb Co. fell$. 27 or. 4 percent, to $60.87. Hospira fell$. 62 or 1.0 percent, to $64.16.

  • Early Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 11:13 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $71.55. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.60. Hospira fell $1.05 or 1.6 percent, to $63.73.

  • Early Glance: Medical Devices companies Friday, 30 Jan 2015 | 11:13 AM ET

    Allergan fell $1.77 or. 8 percent, to $220.62. Baxter International Inc. rose$. 17 or. 2 percent, to $71.55. Boston Scientific Corp. rose$. 02 or. 1 percent, to $14.87.

  • The North Chicago- based company's full results were weighed down by a $2.2 billion breakup fee and other expenses from its abandoned merger with Shire PLC. AbbVie had envisioned buying Shire and reincorporating on the British island of Jersey, where Shire is incorporated. But AbbVie's board got cold feet after the U.S. government created new limitations on...

  • Jan 30- Eli Lilly and Co cut its 2015 revenue forecast, issued earlier this month, as the U.S. drugmaker expects a bigger hit from a stronger dollar. Large U.S. healthcare companies such as Johnson& Johnson, Pfizer Inc and Bristol-Myers Squibb Co have in the past weeks issued 2015 earnings forecasts below Wall Street expectations, citing the stronger dollar.

  • UPDATE 1-U.S. FDA approves Bristol-Myers, J&J HIV pills Thursday, 29 Jan 2015 | 6:35 PM ET

    Jan 29- The U.S. Food and Drug Administration on Thursday approved two fixed-dose HIV pills that combine protease inhibitors- one made by Bristol-Myers Squibb Co and the other by Johnson& Johnson- both with a boosting agent produced by Gilead Sciences Inc.. Bristol-Myers said its drug, Evotaz, is a once-daily pill containing Reyataz, also known as atazanavir, a...

  • Final Glance: Medical Devices companies Thursday, 29 Jan 2015 | 6:14 PM ET

    Allergan rose$. 03 or percent, to $222.39. Baxter International Inc. rose $1.22 or 1.7 percent, to $71.38. Boston Scientific Corp. rose$. 26 or 1.8 percent, to $14.85.

  • Final Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 6:14 PM ET

    Baxter International Inc. rose $1.22 or 1.7 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.14. Hospira rose$. 13 or. 2 percent, to $64.78.

  • Abbott CEO losing no sleep over stronger dollar Thursday, 29 Jan 2015 | 3:15 PM ET

    Jan 29- Abbott Laboratories' chief executive officer is not worried about the stronger dollar, telling analysts on Thursday his company will better withstand its painful effects than rivals due to its European factories and growing sales of nutritional products, medical diagnostics and medical optics. Half of its sales are in emerging markets, like China and...

  • Midday Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $60.72. Hospira fell$. 68 or 1.1 percent, to $63.97.

  • Midday Glance: Medical Devices companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Allergan fell $1.30 or. 6 percent, to $221.06. Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Boston Scientific Corp. rose$. 04 or. 3 percent, to $14.63.

  • The regulator's decision, which comes in over two months ahead of its review date, represents a fourth indication for the drug, sold by Johnson& Johnson and Pharmacyclics Inc. Although WM occurs only in up to 1,500 patients in the United States each year, the approval highlights the strength of the Imbruvica franchise, Roth Capital Partner's Joseph Pantginis...

  • FDA expands use of Imbruvica to treat rare form of cancer Thursday, 29 Jan 2015 | 11:29 AM ET

    Jan 29- The U.S. Food and Drug Administration said it cleared an expanded use of Imbruvica to treat Waldenström's macroglobulinemia, a rare form of cancer that begins in the body's immune system. The approval represents a fourth indication for the drug, sold by Johnson& Johnson and Pharmacyclics Inc, since its initial approval in November 2013.

  • Jan 29- Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, forecast 2015 sales and earnings below analysts' expectations, becoming the latest U.S. healthcare company to warn about a strengthening dollar. The company expects profit to be hit by 58 cents in 2015. It forecast $7.22 to $7.40, excluding special items, below analysts'...

  • Early Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 77 or 1.3 percent, to $60.56. Hospira fell$. 49 or. 8 percent, to $64.16.

  • Early Glance: Medical Devices companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Allergan fell$. 80 or. 4 percent, to $221.56. Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. St. Jude Medical Inc. fell$. 86 or 1.3 percent, to $66.53.